OpenAI Researcher Reportedly Raising $200M at $2B Valuation for AI Drug Startup
VraserX · x · 2026-07-31
An OpenAI researcher is reportedly in talks to raise $200 million at a $2 billion valuation for a new AI-driven drug discovery startup. The move highlights the immense capital power and premium valuation that talent from frontier AI labs currently commands in the market.
More from Companies & People
- AI Startup Eigent Expands to US Hiring Core Team; MiniMax H3 Video Generation Stuns in Test — VoidAsuka · 2026-07-31
- NVIDIA Forms Open Secure AI Alliance to Promote Open Source Defenses — nvidia · 2026-07-31
- RBC Extends Sponsorship with Vector Institute to Advance Enterprise AI — VectorInst · 2026-07-31
- arXiv Appoints Inaugural CEO and Board, Solidifying Nonprofit Transition — lpachter · 2026-07-31
- OpenAI and Anthropic Are Massively Scaling FDE Teams — mobileraj · 2026-07-31
- Gary Marcus Mocks Nadella's Vibe-Coding Financials with Hallucination-Prone AI — GaryMarcus · 2026-07-31